Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

In Other News



view channel
Image: Micrograph of differentiated muscle fibers (green) with cell nuclei shown in blue (Photo courtesy of Dr. Olivier Pourquié, Harvard University Medical School).

Improved Stem Cell Technology Enables Mass Differentiation of Muscle Fiber Cells

Improvements in stem cell technology have enabled the in vitro differentiation and growth of large numbers of muscle fiber cells, including muscle fibers from a mouse model of Duchenne muscular dystrophy.... Read more

Drug Discovery

view channel
Image: Molecular model of phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) (Photo courtesy of Wikimedia Commons).

Mutation Identified That Predicts Response of Breast Cancer to Treatment with Drug Duo

A gene mutation was identified as a biomarker that can predict whether a patient with HER-2 positive breast cancer will respond positively to the most effective dual anti-HER2 treatment.... Read more

Lab Technologies

view channel

Panel of Research-Use-Only Mass-Spec Biomarker Tests Launched at AACC 2015

Over 50 research-use-only (RUO) mass-spectrometry based biomarker tests, to be offered as a laboratory service, were launched during the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA). The RUO tests are specifically designed for detection and quantification of key protein biomarkers in human serum... Read more


view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.